Evaluation of QTc interval in Iranian causalities (Janbazan) of Iran-Iraq war receiving maintenance methadone treatment

Journal of Research in Medical Sciences

Volumn 17, Issue 3, 2012, Pages 12-16

  Abdar, Esfahani M ^d   Vosughi, A K ^a   Fatehi, M H ^b   Shah Sanaei, A ^c   Teimuri, A ^d  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d NONE

Author keywords

Methadone; Methadone maintenance treatment; Prolonged QTC interval; War

Indexed keywords

METHADONE;

ADULT; AGE; AGED; ARTICLE; BODY WEIGHT; CROSS-SECTIONAL STUDY; ELECTROCARDIOGRAPHY; HUMAN; IRAN; IRAQ; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; QT PROLONGATION; TREATMENT DURATION; WAR;

EID: 84859121060     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mori K, Judith M, Barry S, Davendra M, Mark CP. Qtc Interval Screening in methadone treatment. Ann Intern Med 2009; 150:387-39.
2. Fareed A, Vayalapalli S, Byrd-Sellers J, Casarella J, Drexler K, Amar R, et al. Onsite Qtc interval screening for patients in methadone maintenance treatment. J Addict Dis 2010;29:15-22.
3. Reddy S, Hui D, El Osta B, de la Cruz M, Walker P, Palmer JL, et al. The effect of oral methadone on the Qtc interval in advanced cancer patients: A prospective pilot study. J Palliat Med 2010;13:638-9.
4. Wilcock A, Beattie JM. Prolonged. QT interval and methadone implications for palliative care. Curr Opin Support Palliat Care 2009;3:252-7.
5. Huh B, Park CH. Retrospective analysis of low-dose methadone and Qtc prolongation in chronic pain patients. Korean J Anesthesiol 2010;58:338-43.
6. Peles E, Bodner G, Kreek MJ, Rados V, Adelson M. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients-a crosssectional study. Addiction 2007;102:289-300.
7. Cruciani RA, Ryuichi S, Peter H, David L, Ysmael Y, Yukako S, et al. Measurement of Qtc in Patients Receiving Chronic Methadone Therapy. Vol 29.???: U.S. Cancer Pain Relief Committee; 2005. p. 385-91.
8. Krantz M, Lewkowiez I, Hays H, Woodroffe MA, Robertson AD, Mehler PS. Associated with very-high-dose methadone. Ann Torsade de pointes Intern Med. 2002;137:501-4.
9. th ed. China: Elsevier, Saunders publication; 2011. p. 856-85.
10. Ackerman MJ, Tester DJ, Jones GS, Will ML, Burrow CR, Curran ME. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc. 2003;78:1479-87.
11. Benmebarek M, Devaud C, Gex-Fabry M, Powell Golay K, Brogli C, Baumann P, et al. Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone. Clin Pharmacol Ther 2004;76:55-63.
12. Charles IB, Stephan P, Peter JZ, Mark E. Uptodate. Acquired long QT syndrome. Inc.95 Sawyer Rd. Waltham, MA 02453; 2011; version 19.2.
13. Marcmmani I, Pacini M, Cesaroni C, Lovreeic M, Perugi G, Tagliamonte A. Qtc interval prolongation in patients on long-term methadone maintenance therapy. Eur Addict Res 2005;11:44-9.
14. Ehret GB, Voide C, Gex-Fabry M, Chabert J, Shah D, Broes B, et al. Drug-inducet long syndrome in injection drug users receiving methadone: High frequency in hospitalized patients and risk factors. Arch Intern Med 2006;166:1280-7.
15. Cruciani RA, Seline R, Homel P, Lussier D. Yap Y, Suzuki Y, et al. Measurement of QTc in patients receiving chronic methadone therapy. J Pain System Manage 2005;29:358-91.
16. Martell BA, Arnsten JII, Krantz MJ, Gourevitch MN. Impact of methadone treatment on cardiac repolazition and conduction in opioid usere. Am J Cardiol 2005;95:915-8.
17. Martell BA, Arnsten JH, Ray B, Gourevitch MN. The impact of methadone induction on. cardiac conduction in opiate users. Ann Intern Med 2003;139:154-5.
18. Gil M, Sala M, Anguera I, Chapinal O, Cervantes M, Gume JR, et al. QT prolongation and torsades de pointes in patients infected with human immuno deficiency virus and treated with methadone. Am J Cardiol 2003;92:995-7.
19. Krantz MJ, Garcia JA, Mehler PS. Effects of buprenorphine on cardiac repolarization in a patient with merhadone-related torsade de pointes. Pharmacotherapy 2005;25:611-4.
20. Piguet V, Desmeules J, Ehret G, Stoller R, Dayer P. QT interval prolongation in patients on methadone with concomitant drugs. J Clin Psychopharmacol 2004;24:446-8.
21. Famoe S, Hvidt C, Ege P, Jensen GB. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart 2007;93:1051-5.
22. Pearson EC, Woosley RI. QT prolongation and torsades de pointes among methadone users: report to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf 2005;14:747-53.
23. Krantz MJ, Mehler PS. QTc prologation: Methadone's efficacysafery paradox. Lancet 2006;368:556-7.
24. Ansermot N, Albayrak O, Schläpfer J, Crettol S, Croquette-Krokar M, Bourquin M, et al. Substitution of (R, S)-methadone by (R)-methadone: Impact on Qtc interval. Arch Intern Med 2010;170:1407-8; author reply 1408.
25. Eap CB, Crettol S, Rougier JS, Schlapfer J, Sintra Grilo L, Deglon JJ, et al. Stereoselective block of hERG channel by (S)-methadone and QT internal prolongation in CYP2B6 slow metabolizers. Clin Pharmacol Ther 2007;81:719-28.